US FDA approves Takeda, Protagonist's drug for rare blood cancer
- Posted on August 28, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
US FDA approves Takeda, Protagonist's drug for rare blood cancer
By Kamal Choudhury and Mariam Sunny Aug 28 (Reuters) - The U.S. Food and Drug Administration has approved a first-of-its-kind drug from Takeda Pharmaceutical and Protagonist Therapeutics to treat a rare blood cancer, the health regulator said on Friday. The approval of rusfertide brings a highly anticipated, less-invasive treatment option for thousands of patients who have historically relied on
